Benchmark Holdings
Biotechnology solutions for sustainable aquaculture production.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | £13.0m | Private Placement VC |
| Total Funding | 000k | ||
| GBP | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 18 % | 27 % | 7 % | (47 %) | (13 %) | 7 % | 6 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 19 % | 22 % | 22 % | 11 % | 8 % | 20 % | 21 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (10 %) | (20 %) | (14 %) | (44 %) | 43 % | 9 % | 11 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 6 % | 4 % | 4 % | 3 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Benchmark Holdings PLC is a UK-based aquaculture biotechnology company founded in 2000. The company's mission is to enhance sustainability in aquaculture by providing products and solutions that boost farming efficiency, animal health, and welfare. It operates in two main segments: Advanced Nutrition and Health. The Advanced Nutrition division focuses on providing specialized nutrition and health products for the early stages of shrimp, seabass, and seabream growth. The Health division supplies products to the global aquaculture market, including sea lice treatments like Ectosan Vet and Salmosan Vet, and its CleanTreat water purification system.
The business serves over 750 customers across 70 countries, with commercial and R&D operations in 24 nations. Benchmark's business model revolves around developing and selling these specialized products, generating the majority of its revenue from the Advanced Nutrition segment. The company has undergone significant restructuring, including the disposal of its Genetics business, to sharpen its focus on its core aquaculture operations. Its clients are aquaculture producers seeking to improve productivity and sustainability.
The company is led by Chairman Nathan "Tripp" Lane, a founding partner of advisory firm Delancey Cove LLC, and CEO Trond Williksen, former CEO of SalMar ASA and AKVA group ASA. Headquartered in Sheffield, UK, Benchmark Holdings is a public limited company listed on the London Stock Exchange.
Keywords: aquaculture biotechnology, sustainable aquaculture, advanced nutrition, animal health, sea lice treatment, water purification, shrimp nutrition, fish health, salmon farming, marine biotechnology, aquaculture feed, fish farming solutions, Ectosan Vet, CleanTreat, INVE Aquaculture, sustainable food production, animal welfare, aquaculture R&D
Tech stack
Investments by Benchmark Holdings
Edit
